Tag: Aurobindo Pharma
Aurobindo subsidiary gets license to develop and market Nilotinib Capsules in LMICs
Aurobindo Pharma, along with its subsidiary Eugia Pharma Specialities has announced a voluntary sub-licensing agreement with Medicines Patent Pool (MPP) to develop and market Nilotinib ... Read More
Aurobindo Pharma announces FDA final approval for Amphotericin B Liposome for Injection
Aurobindo Pharma said that its fully-owned subsidiary — Eugia Pharma Specialities has secured final approval for Amphotericin B Liposome for Injection, 50 mg from the ... Read More
Aurobindo Pharma oral manufacturing facility gets FDA establishment inspection report
Aurobindo Pharma has been issued an establishment inspection report (EIR) from the US Food and Drug Administration (FDA) for one of its manufacturing facilities in ... Read More
Aurobindo Pharma gets DCGI nod for Molnupiravir generic version
Aurobindo Pharma has secured consent from the Drugs Controller General of India (DCGI) for manufacturing and distributing its generic version of Covid drug Molnupiravir under ... Read More
Aurobindo subsidiary Eugia gets FDA approval for Cyclophosphamide Injection
Aurobindo Pharma said that its subsidiary Eugia Pharma Specialities has secured approval from the US Food and Drug Administration (FDA) for the new drug application ... Read More
Aurobindo Pharma scraps Rs 420cr stake deal with Cronus Pharma
Aurobindo Pharma Limited has scrapped its previously signed binding agreements with Cronus Pharma Specialities India Private Limited, under which it was to acquire a stake ... Read More
Aurobindo Pharma to buy Sandoz US’ dermatology and oral solids businesses
Aurobindo Pharma has agreed to acquire the dermatology business and a portfolio of oral solid products along with commercial and manufacturing infrastructure from Sandoz US, ... Read More
Sandoz US to sell dermatology and oral solids businesses to Aurobindo
Pharma acquisition news : Sandoz US, a subsidiary of Swiss pharma company Novartis, has agreed to sell its dermatology and oral solids businesses to Indian ... Read More